News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    

Biotech/Pharma - Investor
Admedus Completes Fully Subscribed $16.1 Million Rights Issue 4/17/2015
Horizon Pharma (HZNP) Announces Pricing Of Public Offering Of Ordinary Shares 4/17/2015
Akebia Therapeutics, Inc. (AKBA) Prices Public Offering Of Common Stock 4/17/2015
Pernix (PTX) Announces Pricing Of Private Offering Of $130 Million Of 4.25% Convertible Senior Notes Due 2021 4/17/2015
Epizyme (EPZM) Announces Closing Of Common Stock Offering 4/17/2015
Ipsen (IPN.PA), Active Biotech AB (BTPC) Plummet As Prostate Cancer Drug Flunks Late-Stage Trial 4/16/2015
Aduro Biotech (ADRO) Launches $119 Million IPO with Hot Cancer Tech 4/16/2015
Nuvo Research Inc. (NRI.TO) Updates Company Strategy 4/16/2015
Immune Design Corporation (IMDZ) Prices Public Offering Of Common Stock 4/16/2015
Tokyo Stock Exchange Announces New Rule Affecting Trading Of MediciNova, Inc. Stock In Japan 4/16/2015
Galapagos (GLPG.BR) Files Registration Statement In The United States For A Proposed Global Offering 4/16/2015
Pfizer (PFE) Launches 2014 Integrated Annual Review 4/16/2015
InVivo Therapeutics Corporation (NVIV) Announces Uplisting To Nasdaq 4/16/2015
Pernix (PTX) Provides Business Update 4/16/2015
C. R. Bard, Inc. (BCR) Declares Quarterly Dividend 4/16/2015
Pernix (PTX) Announces Private Offering Of $120 Million Of Convertible Senior Notes Due 2021 4/16/2015
BioAegis Therapeutics Completes Initial $8 Million Convertible Note Round; Round Oversubscribed 4/16/2015
Skystar Bio-Pharmaceutical (CGPN) Announces Receipt Of NASDAQ Non-Compliance Letter Due To Delay In Filing Form 10-K 4/16/2015
The Medicines Company (MDCO) Stock Trading Halted Today 4/15/2015
uniQure (QURE) Announces Closing Of Follow-on Public Offering 4/15/2015
Corbus Pharmaceuticals, Inc. Announces Uplisting To The NASDAQ Capital Market 4/15/2015
Akebia Therapeutics, Inc. (AKBA) Announces Proposed Public Offering Of Common Stock 4/15/2015
Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C Represents ImmunoGen (IMGN) In $200 Million Transaction 4/15/2015
Axxess Pharma, Inc. Provides Shareholder Update 4/15/2015
SAGE Therapeutics Announces Pricing Of Public Offering Of Common Stock 4/15/2015
Foamix Pharmaceuticals, Ltd. (FOMX) Announces Upsizing And Pricing Of Its $60 Million Public Offering Of Ordinary Shares 4/15/2015
Aegerion (AEGR) Grants Stock Options Under Inducement Program 4/15/2015
WuXi PharmaTech Co., Ltd. Files 2014 Annual Report On Form 20-F 4/15/2015
Now Infused With Cash, Mysterious H3 Biomedicine About to Get Less Shy About What It Does 4/14/2015
Concordia Healthcare (CXR.TO) Announces Upsizing And Pricing Of Senior Notes Offering 4/14/2015
SAGE Therapeutics Announces Proposed Public Offering Of Common Stock 4/14/2015
Roche (RHHBY) Announces Final Results Of Tender Offer For Foundation Medicine, Inc. (FMI) 4/14/2015
Notice Of Annual General Meeting In Karolinska Development AB 4/14/2015
Siegfried Release: Shareholders’ Meeting Approves All Board Proposals 4/14/2015
Dyax Corp. (DYAX) Closes $230 Million Public Offering Of Common Stock 4/14/2015
Pernix (PTX) Announces Launch Of Consent Solicitation For Its 12% Senior Secured Notes Due 2020 4/14/2015
Horizon Pharma (HZNP) Announces Proposed Public Offering Of Ordinary Shares 4/14/2015
Columbia Laboratories, Inc. (CBRX) Begins Trading As Juniper Pharmaceuticals (JNP) 4/13/2015
PTC Therapeutics (PTCT) Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) 4/13/2015
Roaring Juno Therapeutics (JUNO) Ends Quest for New Headquarters and Blueprints Plans to Keep Investors Happy 4/10/2015
Death Possibly Linked to Biogen (BIIB) Tecfidera "No Cause for Alarm," Says Analyst 4/10/2015
Mylan (MYL) Offers $30 Billion Bid for Irish Perrigo Company (PRGO), As Share Price Skyrockets 4/10/2015
uniQure (QURE) Announces Pricing Of Follow-On Public Offering 4/10/2015
Cellular Biomedicine Group (CBMG) Upgraded To NASDAQ Global Market 4/10/2015
Galena Biopharma  (GALE) Announces Closing Of Over-Allotment Option, Increasing Total Gross Proceeds To $43.7 Million 4/10/2015
Cerulean Pharma Inc. (CERU) Closes Public Offering Of Common Stock 4/10/2015
Oxis Biotech Inc. Announces Resumption Of Trading Of Common Stock On Euronext Paris 4/10/2015
Antibe Therapeutics Inc. (ATE.V) Completes Final Closing Of Non-Brokered Private Placement Bringing Total Proceeds To $1,250,000 4/10/2015
As AbbVie (ABBV) Eyes Alzheimer's Franchise, Speculation Mounts About a $4.5B Marriage to Acadia (ACAD) 4/9/2015
Conatus Pharma Announces Completion Of Public Offering And Full Exercise Of Underwriters' Option To Purchase Additional Shares 4/9/2015
Ceres, Inc. Announces One-For-Eight Reverse Stock Split 4/9/2015
Rhinomed (ASX:RNO) Shareholder Update 4/9/2015
Resolutions Of The Annual Shareholders’ Meeting Of Sartorius AG 4/9/2015
Resolutions Of The Annual Shareholders’ Meeting Of Sartorius AG 4/9/2015
Opexa Therapeutics (OPXA) Announces Completion Of Rights Offering 4/9/2015
Inovio Pharmaceuticals (INO)’ HPV Immunotherapy Recognized As "Best Therapeutic Vaccine" By World Vaccine Congress 4/9/2015
Lonza Group Ltd. (LZAGY.PK) Announces Results Of Annual General Meeting Annual General Meeting Accepts All Motions Proposed By Board Of Directors 4/8/2015
Dyax Corp. (DYAX) Announces Pricing Of $200 Million Public Offering Of Common Stock 4/8/2015
“Batten Down the Hatches” But Look For Opportunity in Rough First Quarter, Says Analyst 4/8/2015
Egalet Announces Closing Of $60 Million Offering of Convertible Senior Notes Due 2020 4/8/2015
Replicel Life Sciences Receives TSX Venture Exchange Approval To Extend Warrant Expiry Dates 4/8/2015
Lexicon Pharmaceuticals, Inc. (LXRX) To Ring The Nasdaq Stock Market Closing Bell 4/8/2015
Trillium Therapeutics Inc. Announces Completion Of Public Offering Of Securities 4/8/2015
Prothena (PRTA) Announces Pricing Of Public Offering Of 3,300,000 Ordinary Shares 4/8/2015
Cellular Biomedicine Group (CBMG) Responds To False Statements And Allegations Made By Short Seller 4/8/2015
uniQure (QURE) Announces Launch Of Follow-On Public Offering 4/8/2015
Raptor Pharmaceutical Inc. (RPTP) Announces Closing Of Underwritten Public Offering And Exercise In Full of Underwriters' Option To Purchase Additional Shares 4/8/2015
InVivo Therapeutics Corporation (NVIV) Announces Implementation Of Reverse Stock Split In Preparation For Planned Uplisting To NASDAQ 4/8/2015
Gilead (GILD) and Amgen (AMGN) Hand Out Dividends; Other Biotechs Feel the Heat So Who's Next? 4/7/2015
CeraPedics, Inc. Announces Closing Of Loan And Equity Financing 4/7/2015
Intercept Pharmaceuticals (ICPT) Announces Completion Of Public Offering 4/7/2015
Prothena (PRTA) Announces Proposed Offering of Ordinary Shares 4/7/2015
Concordia Healthcare (CXR.TO) Announces Proposed Private Offering Of US$610 Million Senior Notes Due 2023 4/7/2015
Cerulean Pharma Inc. (CERU) Announces Pricing Of Public Offering Of Common Stock 4/7/2015
Dyax Corp. (DYAX) Announces Proposed Public Offering Of 7,000,000 Shares Of Common Stock 4/7/2015
CEO Open Letter To Shareholders Of Hasco Medical, Inc. (HASC) 4/7/2015
GeoVax Labs Inc. (GOVX.OB) Issues Letter To Shareholders 4/7/2015
Teva (TEVA)'s Recent Moves Suggest Restructuring Will Focus on Hypertension, Respiratory & CNS Markets 4/6/2015
Analyst: A Complete List of All Major Biosimilars Could Be the A to Z Guide 4/6/2015
Mallinckrodt (MNK) Launches Notes Offering 4/6/2015
Kythera (KYTH) Grants Stock Options Under Inducement Program 4/6/2015
Cortex Pharmaceuticals, Inc. (COR) Files December 31, 2014 Annual Report On Form 10-K; Provides Update On Current Status And Activities 4/6/2015
Relypsa (RLYP) Announces New Employment Inducement Grants 4/6/2015
Opexa Therapeutics (OPXA) Reminds Shareholders That Rights Offering Expires On April 8, 2015 At 5:00 PM ET 4/6/2015
NuGene International, Inc. Reports Increase In Sales, Significant Developments In 2014 4/6/2015
Synta Pharmaceuticals (SNTA) Closes Public Offering Of Common Stock 4/6/2015
Insmed Incorporated (INSM) Announces Closing Of Public Offering And Exercise Of Option To Purchase Additional Shares 4/6/2015
NanoViricides, Inc. (NNVC.PK) Provides An Update On Its Progress Over The Last Quarter 4/6/2015
Theravance (THRX) Announces New Employment Inducement Awards 4/6/2015
IPOs Dropped 54 Percent in the First Quarter, As VC Investment Stays on the Sidelines 4/6/2015
Regen BioPharma CEO Discusses Recent Financings, New Laboratory Facilities And Preferred Stock Dividend 4/3/2015
WuXi PharmaTech Co., Ltd. Lists Shares Of Small-Molecule Manufacturing Subsidiary STA On New Third Board In China 4/3/2015
ImmuDyne, Inc. (IMMD) Progress Report 4/3/2015
IntelGenx Corp. Grants Stock Options 4/3/2015
ProtoKinetix Inc. (PKTX.OB) Announces Share Issuance 4/3/2015
Former Allergan (AGN) CEO Pyott Sees $534M Cash Payday After Stock Sale 4/2/2015
Amgen (AMGN) in the Crosshairs As Biogen (BIIB), Hospira, Merck & Co. (MRK) All Climb on Biosimilar Bandwagon: Citi 4/2/2015
Trinity Biotech plc Announces Proposed Offering Of $100 Million Of Exchangeable Senior Notes Due 2045 4/2/2015
Salix (SLXP) Provides Notice of Fundamental Changes, Make-Whole Fundamental Changes And Merger Event Relating To Its 1.5% Convertible Senior Notes Due 2019 4/2/2015
Imprimis Pharmaceuticals (immy) Announces 2015 Annual Meeting Of Stockholders 4/2/2015
Conatus Pharma Announces Proposed Public Offering Of Common Stock 4/2/2015
Foamix Pharmaceuticals, Ltd. (FOMX) Files Registration Statement For Proposed Follow-On Offering 4/2/2015
Raptor Pharmaceutical Inc. (RPTP) Announces Pricing Of Public Offering Of Common Stock 4/2/2015
Conatus Pharma Announces Pricing Of Public Offering Of Common Stock 4/2/2015
Mesa Labs (MLAB) Declares Quarterly Dividend 4/2/2015
PlasmaTech Biopharmaceuticals' Announces $5 Million Private Placement 4/2/2015
Trinity Biotech plc Prices Offering Of $100 Million Of 4.00% Exchangeable Senior Notes Due 2045 4/2/2015
BTG plc (BTG.L): Close Period Update 4/2/2015
GTx, Inc. (GTXI) Provides Corporate Update Regarding NASDAQ Stock Listing 4/2/2015
Cellceutix (CTIX) Enters Into A $30 Million Common Stock Purchase Agreement 4/2/2015
Conversion Right Triggered On Opko Health, Inc. (OPK) 3.0% Convertible Senior Notes 4/2/2015
Adamis (ADMP) Plummets More Than 30% After FDA Rejects Its Allergy Shot Application 4/1/2015
Mylan N.V. Announces Pricing Of Secondary Public Offering Of A Portion Of Abbott (ABT)'s Ordinary Shares 4/1/2015
Valeant (VRX) Completes Tender Offer For Salix (SLXP) 4/1/2015
Grifols (GRFS) 2014 Annual Report On Form 20-F Filed With The SEC On April 1, 2015 4/1/2015
Novavax, Inc. (NVAX) Announces Closing Of Public Offering 4/1/2015
Inogen (INGN)To File Form 12b-25 With Securities And Exchange Commission 4/1/2015
Trillium Therapeutics Inc. Announces Pricing Of Public Offering Of Securities 4/1/2015
Coherus Biosciences Prices Upsized Public Offering Of $120.0 Million Of Common Stock 4/1/2015
Egalet Announces Proposed $60 Million Offering Of Convertible Senior Notes Due 2020 4/1/2015
Cardio3 BioSciences Announces Intention To Conduct A Registered Public Offering In The United States 4/1/2015
Omnicell Regains Nasdaq Listing Compliance 4/1/2015
PlasmaTech Biopharmaceuticals Provides Strategic Update For 2015 And Review Of 2014 Acheivements 4/1/2015
Redemption Of All Of Salix (SLXP)'s Outstanding 6.00% Senior Notes Due 2021 4/1/2015
De Blasio Administration Launches Major Funding Initiative To Create Thousands Of Jobs In City's Life Sciences Sector 4/1/2015
Chairman Of Jintian Pharmaceutical Purchased Approximately HK$113 Million Worth Of Shares Citing Confidence In Company's Development In Online And Offline Macrohealth Business 4/1/2015
Flex Pharma (FLKS) Added To Russell 3000®, Russell 2000, And Russell Microcap Indices 4/1/2015
Dicerna (DRNA) Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) 4/1/2015
PetLife Pharmaceuticals Provides Shareholder Update 4/1/2015
VC Firms Band Together to Launch $150M NYC Biotech Fund, Bringing 2,000 New Jobs to the City 4/1/2015
Intercept Pharmaceuticals (ICPT) Announces Proposed Offering Of Common Stock 3/31/2015
XTL Biopharmaceuticals Ltd. (XTLB) Announces Pricing Of $4.0 Million Registered Direct Offering 3/31/2015
OXIS International, Inc. (OXIS) Announces Request For Euronext Trading Suspension 3/31/2015
Scilex Pharmaceuticals Announces Strategic Investment By Itochu Chemical Frontier Corporation 3/31/2015
Intercept Pharmaceuticals (ICPT) Announces Pricing Of Public Offering Of Common Stock 3/31/2015
Meda AB (MEDA-A.ST) (publ) Notice Of Annual General Meeting 2015 3/31/2015
Synta Pharmaceuticals (SNTA) Prices Public Offering Of Common Stock 3/31/2015
Insmed Incorporated (INSM) Announces Pricing Of Public Offering Of Common Stock 3/31/2015
NeuroVive Pharmaceutical AB (publ) - Amendment Number Of Shares And Votes 3/31/2015
Cerulean Pharma Inc. (CERU) Announces Proposed Public Offering Of Common Stock 3/31/2015
Synta Pharmaceuticals (SNTA) Announces Proposed Public Offering Of Common Stock 3/31/2015
Horizon Pharma (HZNP) To Acquire Hyperion Therapeutics (HPTX) For $46.00 Per Share Or $1.1 Billion In Cash 3/30/2015
MorphoSys AG Tanks 20% on Celgene (CELG) Cancer Pact Breakup News 3/30/2015
Raptor Pharmaceutical Inc. (RPTP) Announces Proposed Public Offering Of Common Stock 3/30/2015
Can-Fite BioPharma (CFBI) Files 2014 Annual Report On Form 20-F 3/30/2015
Coherus Biosciences Announces Proposed Public Offering Of Common Stock 3/30/2015
Trillium Therapeutics Announces Proposed Public Offering Of Securities 3/30/2015
Insmed Incorporated (INSM) Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) 3/30/2015
MultiVir Files Registration Statement For Proposed Initial Public Offering 3/30/2015
Mylan N.V. Announces Commencement Of Secondary Public Offering Of A Portion Of Abbott (ABT)'s Ordinary Shares 3/30/2015
Innocoll AG Secures EUR 25 Million Loan Commitment From European Investment Bank (EIB) 3/30/2015
Covalon Technologies Ltd. Announces Issuance Of Stock Options 3/30/2015
Eli Lilly (LLY) Announces Date For Diabetes Investor Meeting 3/30/2015
Synergy Pharmaceuticals May Be for Sale 3/27/2015
SurePure Completes Verification And Approved For Trading On The OTCQB Marketplace 3/27/2015
Galapagos (GLPG.BR) Release: Publication Of Annual Report 2014 And Invitation To The Annual Shareholders' Meeting To Be Held On 28 April 2015 3/27/2015
Johnson & Johnson (JNJ) To Webcast Annual Meeting Of Shareholders 3/27/2015
Valeant (VRX) Closes Offering Of $1.45 Billion Of Common Shares 3/27/2015
Analyst: First Quarter Market Meltdown Just "Clockwork," As Biogen (BIIB), Celgene (CELG) Reign 3/27/2015
Conatus Pharma Shares Soar On Successful Emricasan Phase II Results 3/27/2015
CAR-T, Checkpoint Inhibitors and Vaccines All Key at Crucial Conference, Says Cowen and Company 3/27/2015
Cardica, Inc. (CRDC) To Host Business Update Conference Call 3/26/2015
Early-Stage Biotech Star Flagship Ventures Scores $537M for New Fund 3/26/2015
Why Your Last Investment Blew Up 3/26/2015
Pivotal Therapeutics Inc. Announces Payment Of Interest On Outstanding Convertible Notes 3/26/2015
MabVax Therapeutics, Inc. Enters Into Exchange Agreements To Issue Common Stock And Series D Preferred Stock Eliminating Series A-1 And B Convertible Preferred And Related Warrants 3/26/2015
Notice Of Annual General Meeting In Biotage AB (BIOTa.ST) (Publ) 3/26/2015
Becton, Dickinson and Company (BDX) To Commence Exchange Offers 3/26/2015
Novavax, Inc. (NVAX) Prices Public Offering Of Common Stock 3/26/2015
Sucampo Pharmaceuticals, Inc. (SCMP) Prices Public Offering Of Common Stock By Selling Stockholders 3/26/2015
SteadyMed (STDY) Announces Closing of Initial Public Offering 3/26/2015
Sucampo Pharmaceuticals, Inc. (SCMP) Announces Proposed Public Offering By Selling Stockholders 3/26/2015
Omnicell Receives Expected Nasdaq Notification Of Noncompliance 3/25/2015
Haemonetics Corporation (HAE) Sets Date For Investor/Analyst Meeting - May 19, 2015 3/25/2015
ZS Pharma (ZSPH) Announces Upsizing And Pricing Of $186 Million Public Offering Of Common Stock 3/25/2015
Novavax, Inc. (NVAX) Announces Proposed Public Offering Of Common Stock 3/25/2015
Oxis Biotech Inc. Announces Corporate Update Conference Call For March 31 3/25/2015
EPIRUS Biopharmaceuticals To Host Biosimilar Key Opinion Leader Meeting And Webcast On March 30 3/25/2015
Nasdaq Welcomes Cellectis (ALCLS) The Nasdaq Stock Market 3/25/2015
Tekmira (TKMR) Announces Completion Of Underwritten Public Offering Of Common Shares 3/25/2015
Notice of General Meeting In Probi AB (publ) 3/25/2015
Nolato AB ( NOLA-B.ST): Notice Of The 2015 Annual General Meeting 3/25/2015
Newron Pharmaceuticals (NWRN) Shareholders Authorize Allocation Of Additional Shares To Support Multiple Clinical Programs 3/25/2015
Cellectis (ALCLS) Prices Initial Public Offering Of American Depositary Shares 3/25/2015
Merck & Co. (MRK) Announces New $10 Billion Share Repurchase Program 3/25/2015
Retrophin (RTRX) Closes Public Offering Of 7,866,000 Shares Of Common Stock And Full Exercise Of Underwriters’ Option To Purchase Additional Shares 3/25/2015
Concert Pharmaceuticals, Inc. (CNCE) Announces Completion Of Public Offering 3/25/2015
Nordic Nanovector: Nano – Mandatory Notification Of Trade 3/25/2015
Buy This Stock to Bet on Biogen (BIIB) Drug, Says Raymond James & Associates 3/24/2015
Anthera Pharmaceuticals, Inc. (ANTH) Announces Completion Of Public Offering Of Common Stock 3/24/2015
Blueprint Medicines Files Registration Statement for Proposed Initial Public Offering 3/24/2015
ZS Pharma (ZSPH) Announces Proposed Public Offering Of Common Stock 3/24/2015
InVivo Therapeutics Corporation (NVIV) Announces Reverse Stock Split In Preparation For Planned Uplisting To NASDAQ 3/24/2015
Pfizer (PFE) Invites Public To View And Listen To Webcast Of April 28 Conference Call With Analysts 3/24/2015
Newron Pharmaceuticals (NWRN) Shareholders Authorize Allocation Of Additional Shares To Support Multiple Clinical Programs 3/24/2015
Biogen (BIIB) Slides For Alzheimer's Drug Wow Analysts, Set Up Fight for Eli Lilly (LLY) 3/23/2015
Lpath, Inc. (LPTN) To Hold Investor Update Conference Call 3/23/2015
Capstone Therapeutics (CAPS) Announces Operating Update Conference Call 3/23/2015
Convening Notice For 2015 Annual General Meeting In Precise Biometrics AB (Publ) 3/23/2015
Notice Of Annual General Meeting In Bioinvent International AB 3/23/2015



//-->